here - The Chartered Society of Physiotherapy

More documents

Recommendations

Info

(2003), the Cochrane review on standard physiotherapy. This gave a total of 19 trials including standard physiotherapy (Table 2.2). These involved various comparisons (34 in all) encompassing other standard physiotherapy interventions (home exercises, supervised physiotherapy) and pharmacological interventions. Intervention Number of reports Standard physiotherapy 19 Acupuncture 1 Corticosteroid injection 9 Hyaluronate injection 2 Capsular distension 5 Manipulation under anaesthetic 2 Supervised neglect 1 TABLE 2.2. Included trials by intervention (or comparison). Some reports are included in more than one category. This table incorporates trials identified in Green, Hetrick and Buchbinder (2003), the Cochrane review on standard physiotherapy interventions. Detailed descriptions of these trials are given in (APPENDIX B: Table of included trials). 31
2.2. Methodological quality of trials considered for inclusion The methodological quality of trials considered for inclusion is summarised in TABLE 2.3. Trial Eligibility criteria specified Random allocation Concealed allocation Buchbinder et al (2007) Bulgen et al (1984) Calis et al (2006) Carette et al (2003) * Cheing, So and Chao (2008) Dacre, Beeney and Scott (1989) Ginn and Cohen (2005) Guler-Uysal and Kozanoglu (2004) Johnson et al (2007) Khan et al (2005) Kivimäki et al (2007) Lee et al (1973) Leung and Cheing (2008) Nicholson (1985) Pajareya et al (2004) † Ryans et al (2005) Van der Windt et al (1998) Vermeulen et al (2006) Yang et al (2007) TABLE 2.3. Methodological quality of trials considered for inclusion. *Analyses were adjusted for unequal distribution of gender. †Reportedly yes, but not done in analysis. (Verhagen et al 1998, http://www.pedro.fhs.usyd.edu.au/) The median sample size was 80 (range 18–149; interquartile range 41–104), and about half of the trials (9/19) were of good methodological quality (low risk of bias). In the remainder there were deficiencies in random allocation (Guler-Uysal & Kosanoglu 2004), allocation concealment (Bulgen et al 1984, Calis et al 2006, Cheing, So & Chao 2008, Dacre, Beeney & Scott 1989, Guler-Uysal & Kosanoglu 2004, Khan et al 2005, Nicholson 1985); or blinding of assessors (Calis et al 2006, Johnson et al 2007, Khan et al 2005). Each of these methodological deficiencies has been 32 Groups similar at baseline Blinding of subjects Blinding of therapists Blinding of assessors Intention-to-treat Point measures and measures of variability
Page 1 and 2: Eviidence-based clliiniicall guiide
Page 3 and 4: TABLE of CONTENTS Including main fi
Page 5 and 6: Acknowledgements The Guidelines Dev
Page 7 and 8: In the UK in particular, this leave
Page 9 and 10: Protocol As a measure against intro
Page 11 and 12: equired respondents to state whethe
Page 13 and 14: References to Introduction Buchbind
Page 15 and 16: Movements at the shoulder joint are
Page 17 and 18: descriptor, ‘long-life disease’
Page 19 and 20: then monarticular rheumatoid arthri
Page 21 and 22: Differential diagnosis between cont
Page 23 and 24: 1.2a), the tester can limit trunk r
Page 25 and 26: An overview of treatment options Th
Page 27 and 28: Manual mobilisations Background: Ma
Page 29 and 30: attributed to SWD and PSWD (see abo
Page 31 and 32: 1.8. References to Part 1 Buchbinde
Page 33 and 34: Kelley MJ, McClure PJ, Leggin BG (2
Page 35: 2. Systematic review and meta-analy
Page 39 and 40: Trial Eligibility criteria specifie
Page 41 and 42: 36 FIGURE 2.1 Functional outcome, m
Page 43 and 44: the 95% CI, a similarly directional
Page 45 and 46: study sample. This effect was not s
Page 47 and 48: Adjusted threshold for MCID (calcul
Page 49 and 50: Patient-completed section of ASES,
Page 51 and 52: Interpretation: There was no substa
Page 53 and 54: Adverse events, short term (5 weeks
Page 55 and 56: 50 FIGURE 2.8 Functional outcome (S
Page 57 and 58: 52 FIGURE 2.12 Passive external rot
Page 59 and 60: Interpretation: A clinically import
Page 61 and 62: physiotherapy in the pooled study s
Page 63 and 64: separately, whereas Ryans et al (20
Page 65 and 66: Adjusted threshold for MCID: MCID n
Page 67 and 68: Adjusted threshold for MCID (based
Page 69 and 70: Jüni P, Witschi A, Bloch R, Egger
Page 71 and 72: 3. Recommendations for management o
Page 73 and 74: the population, muscle function ret
Page 75 and 76: 3.1.6. In secondary care, should we
Page 77 and 78: outcomes, at this time point and lo
Page 79 and 80: physiotherapy with passive mobilisa
Page 81 and 82: Recommendation: Probably add outpat
Page 83 and 84: Physiotherapy versus other physioth
Page 85 and 86: Physiotherapy versus other treatmen
Page 87 and 88:
Adding physiotherapy to other treat
Page 89 and 90:
Facilitators Barriers CSP accredita
Page 91 and 92:
4. Recommendations for research App
Page 93 and 94:
Ginn KA, Cohen ML (2005). Exercise
Page 95 and 96:
APPENDIX A: Methods i. Types of stu
Page 97 and 98:
vi. Search methods for identificati
Page 99 and 100:
We excluded those which: excluded
Page 101 and 102:
ix. Grading the quality of evidence
Page 103 and 104:
GRADE Working Group (2004) Grading
Page 105 and 106:
Notes More patients in the placebo
Page 107 and 108:
Accepted outcomes Period of data co
Page 109 and 110:
showed any advantage which was clin
Page 111 and 112:
Intervention/ Comparison(s) Accepte
Page 113 and 114:
Notes Group averages (means?) were
Page 115 and 116:
Accepted outcome(s) Period of data
Page 117 and 118:
Intervention/ Comparison(s) Accepte
Page 119 and 120:
APPENDIX C: Table of excluded studi
Page 121 and 122:
1st Author Year Target condition In
Page 123 and 124:
1st Author Year Target condition In
Page 125 and 126:
Cleland J, Durall CJ (2002). Physic
Page 127 and 128:
Thomas E, van der Windt DAWM, Hay E
Page 129 and 130:
Improvement in pain score (follow-u
Page 131 and 132:
Author(s): Ginn and Cohen (2005) (a
Page 133 and 134:
Improvement in VAS for night pain (
Page 135 and 136:
Author(s): Vermeulen et al (2006) (
Page 137 and 138:
Author(s): Leung and Cheing (2008)
Page 139 and 140:
Author(s): Leung and Cheing (2008)
Page 141 and 142:
Improvement in VAS for night pain (
Page 143 and 144:
Author(s): Ginn and Cohen (2005) Qu
Page 145 and 146:
Author(s): Ginn and Cohen (2005) Qu
Page 147 and 148:
iii. Physiotherapy versus combinati
Page 149 and 150:
Improvement in passive external rot
Page 151 and 152:
Improvement in pain (global) on 10-
Page 153 and 154:
v. Adding physiotherapy elements to
Page 155 and 156:
Passive external rotation (follow-u
Page 157 and 158:
Improvement in pain (follow-up 6 we
Page 159 and 160:
APPENDIX F: Delphi panellists Our i
Page 161 and 162:
Comments/suggestion 23 The use of y
Page 163 and 164:
APPENDIX I: Guidelines Development
show all

here - The Chartered Society of Physiotherapy

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?